← Back to Search

Cancer Vaccine

BCG Group for Coronavirus (BADAS Trial)

Phase 4
Waitlist Available
Led By Moshe Arditi, MD
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

BADAS Trial Summary

This trial will test whether BCG vaccination can reduce HCW infection and disease severity during the epidemic phase of SARS-CoV-2.

Eligible Conditions
  • Coronavirus
  • Coronavirus Infection

BADAS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Anyone can participate, regardless of gender.

BADAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of COVID 19 Infection
Secondary outcome measures
Disease Severity

BADAS Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BCG GroupExperimental Treatment1 Intervention
FDA-approved BCG Tice strain, procured from Merck, will be used. The vaccine will be reconstituted according to the package insert. In brief, a vial containing ~1x10^8 CFU of lyophilized BCG will be reconstituted in 50 mL of saline. A single dose will consist of 0.1 mL (~2x10^5 CFU) will be administered by slow intradermal injection using a 25 gauge/ 0.5 mm syringe in the deltoid area.
Group II: Placebo GroupPlacebo Group1 Intervention
A single dose will consist of 0.1 mL saline
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BCG vaccine
FDA approved

Find a Location

Who is running the clinical trial?

Baylor College of MedicineOTHER
997 Previous Clinical Trials
6,000,219 Total Patients Enrolled
M.D. Anderson Cancer CenterOTHER
2,958 Previous Clinical Trials
1,796,649 Total Patients Enrolled
Cedars-Sinai Medical CenterOTHER
497 Previous Clinical Trials
162,681 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the ceiling of enrolment for this clinical trial?

"This trial is no longer accepting participants as the last update was on October 18th, 2022. However, there are 93 trials searching for coronaviridae patients and 21 trials seeking BCG Group candidates currently open to enrollment."

Answered by AI

Could you explain what ailments BCG Group is typically utilized to address?

"BCG Group is a form of therapy employed to treat tuberculosis (tb), urological carcinoma recurring, and in situ carcinomas of the bladder."

Answered by AI

Are researchers still enrolling participants in this experiment?

"Per the information present on clinicaltrials.gov, this research is not currently enrolling patients; however it was initially announced 20 April 2020 and last updated 18 October 2022. At the moment there are 114 alternative trials actively seeking participants."

Answered by AI

Has the BCG Group been given regulatory approval by the Food and Drug Administration?

"The safety of the BCG Group has earned a score of 3 due to its status in Phase 4 trials, which indicates that it is already approved for therapeutic use."

Answered by AI

Does the age requirement for this medical trial extend beyond 75 years?

"The target demographic for this trial are individuals aged 18 and above, but who have not yet reached their 75th birthday."

Answered by AI

Who has the qualifications to be included in this clinical trial?

"This clinical trial is seeking 1800 participants infected with coronaviridae between the ages of 18 and 75. Essential requirements for applicants include being either male or female, as well as supplying 25 hours a week worth of direct patient care to those who are COVID-positive or suspected to be so."

Answered by AI

Has the BCG Group conducted any other studies of a medical nature?

"As of now, 7 Phase 3 BCG Group clinical trials are active and 21 studies related to the medication have been launched. The majority of these investigations take place in Nashville, Tennessee yet there are 61 sites where patients can be recruited for research."

Answered by AI

Is this an innovative clinical trial?

"At the present time, BCG Group have 21 experiments running across 14 countries and 26 cities. Their first trial, hosted by Kael-GemVax Co., Ltd. in 2007 involved 54 patients and achieved Phase 2 drug approval status. Since then, 63 additional studies have been carried out."

Answered by AI
~366 spots leftby Mar 2025